Overview

4.8 out of 5 (80 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

28 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6820 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8101.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Afatinib is a tyrosine kinase inhibitor for managing non–small cell lung carcinoma (NSCLC). Afatinib is designed to cause irreversible inhibition of the ErbB family of tyrosine kinases. The FDA has approved afatinib for treating locally advanced or metastatic NSCLC characterized by nonresistant epidermal growth factor receptor (EGFR) mutations. Additionally, it is a second-line option for advanced squamous NSCLC. Beyond these applications, afatinib is being investigated as a monotherapy for individuals with HER2-positive breast cancer who have experienced progression despite management with trastuzumab. This activity aims to familiarize healthcare providers with afatinib's approved indications and mechanism of action while addressing potential adverse reactions and highlighting considerations regarding toxicity.


UAN: JA4008338-0000-23-168-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of afatinib.

  • Determine the possible adverse effects of afatinib.

  • Implement appropriate monitoring for patients undergoing afatinib therapy.

  • Develop interprofessional team strategies for enhancing care coordination and communication to advance afatinib use and improve outcomes.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-168-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Alana H. on 8/23/2021

thomas on 8/30/2021

Adam T. on 10/17/2021

John S. on 11/24/2021

Anne C. on 3/28/2022

Stephen A. on 6/1/2022

Diane L. on 6/2/2022

Shannon j. on 6/27/2022

Nicole F. on 8/30/2022

Sara M. on 9/20/2022

Li Mei L. on 11/22/2022

Chet B. on 12/5/2022

Li Mei L. on 2/7/2023

Daniel H. on 4/13/2023

daniel h. on 6/9/2023

Amber S. on 6/12/2023

Michele N. on 7/8/2023

Dawn B. on 8/22/2023

Allynda H. on 8/29/2023

Kelly K. on 8/26/2023

Richard D. on 9/22/2023

Essam M. on 10/10/2023

Linda G. on 11/25/2023

Benjamin B. on 12/10/2023

Kishlay A. on 12/9/2023

Great review.

Richard P. on 12/10/2023

Raymond S. on 12/16/2023

Richard S. on 12/20/2023

Melissa W. on 12/24/2023

Nitin M. on 12/29/2023

Maria D. on 1/11/2024

Tamara H. on 1/23/2024

Alexandra J. on 1/31/2024

Good review.

Richard P. on 2/25/2024

Fariborz M. on 3/7/2024

Elizabeth B. on 3/8/2024

885 d. on 3/11/2024

Joseph F. on 3/12/2024

Mark A. on 3/16/2024

MARK J. on 3/17/2024

Excellent program

joerg r. on 3/18/2024

douglas t. on 3/27/2024

Yashpal m. on 4/6/2024

Patricia C. on 4/14/2024

Samantha P. on 4/16/2024

Andrew B. on 4/21/2024

Gauhar K. on 5/5/2024

DUSTIN S. on 5/7/2024

Charles j. on 5/14/2024

Mary A. on 5/20/2024

Stephanie F. on 5/29/2024

Laura M. on 6/3/2024

Leonid K. on 6/8/2024

Hilina y. on 6/20/2024

Nancy L. on 7/20/2024

Oscar K. on 7/25/2024

Hung K. on 8/13/2024

Mark O. on 8/21/2024

William K. on 8/22/2024

Gabriel D. on 9/12/2024

BARBARA Y. on 9/12/2024

Sarah B. on 9/12/2024

Gabriella Q. on 9/12/2024

Nicole G. on 9/25/2024

Jennifer R. on 9/27/2024

Sara C. on 10/9/2024

Alexis K. on 10/11/2024

Janielle D. on 10/22/2024

MICHELLE P. on 11/17/2024

Dayana C. on 11/22/2024

Sherri F. on 11/23/2024

Good course.

Debra P. on 11/24/2024

Pedro G. on 11/24/2024

Adriana S G. on 11/27/2024

Andrea R. on 11/29/2024

Ohama F. on 12/2/2024

Surayma P. on 12/6/2024

Amniel A. on 12/12/2024

David C. on 12/14/2024

Monica L. on 12/16/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6820 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8101.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user